Sparkassen, Germany's largest banking network, has launched Bitcoin trading through the DekaBank app, marking a significant step in integrating cryptocurrency access into traditional retail banking. This move allows Sparkassen customers to trade Bitcoin within a regulated banking environment, reducing onboarding friction and counterparty risks compared to standalone crypto exchanges. While specific product details such as custody, fees, and eligibility are yet to be disclosed, this development signals broader institutional acceptance and easier access for retail investors, especially those previously hesitant due to complexity or regulatory concerns. Customers are advised to verify product specifics and regional availability before trading.
Sparkassen's launch of Bitcoin trading via the DekaBank app comes as a backdrop to a broadly positive day for cryptocurrencies on Pluang. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 19, 2026 21:22 WIB: out of 50 major cryptocurrencies, 40 rose and 9 fell today. Notable movers include EOS at Rp12.649 with an 8.13% increase and a typical hold time of 87 days, ATOM at Rp31.474 up 6.18% with 77% buy order activity and a 61-day hold time, and DOT at Rp20.369 rising 5.46% with 89% buy order activity and a 121-day hold time.
Bill Gross, a serial entrepreneur behind over 175 companies, has launched Idealab.ai, a platform using AI to generate and share over 1.2 million business ideas based on real-world problems. The platform aims to lower barriers to entrepreneurship by h...
The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...
AIOS Tech Inc. announced an agreement to acquire SmartCore Holdings Limited in an all-stock transaction valued at approximately $100 million. The deal will issue 33.3 million AIOS shares to SmartCore's sellers, who will hold about 80% of AIOS shares ...
XBiotech announced positive results from the Phase II TASKIN trial, where their antibody vilamakitug combined with standard chemotherapy improved 12-month overall survival to 61.3% in refractory metastatic colorectal cancer patients, surpassing the s...
Proof and Circle Internet Group demonstrated a new system where AI agents can prove the identity of the person they represent using Proof's x401 open identity protocol and pay merchants in USDC via Circle's x402 payment protocol. This innovation addr...
